Literature DB >> 1916760

A 5'-truncated c-myc gene variant not associated with a risk of cancer.

N S Pellegata1, G Bergamaschi, D Amadori, A Aloia, P Ballarini, L Del Senno, L Amaducci, G N Ranzani.   

Abstract

By analyzing c-myc specific fragments from white blood cell DNAs of 98 gastric cancer patients and 46 control subjects, we observed 6 unexpected patterns due to presence of a variant c-myc gene in addition to the normal gene. Restriction enzyme mapping indicated that the variant c-myc gene was the result of a 5' deletion including the first exon and part of the first intron. The deleted region, non-coding for the functional c-myc protein, contains sequences involved in the regulation of transcription. We therefore analyzed the c-myc mRNAs from a subject carrying the truncated gene and from a subject homozygous for the normal gene in Northern blotting experiments: the mRNAs were indistinguishable, both qualitatively and quantitatively. Family analysis demonstrated that the truncated gene is inherited in a Mendelian fashion. Population studies showed that the allele, both in patients and in control subjects, reaches a polymorphic frequency (2.1% for the whole sample) and that it is not associated with a risk of cancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1916760     DOI: 10.1007/bf00209016

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  18 in total

1.  The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles.

Authors:  C A Spencer; R C LeStrange; U Novak; W S Hayward; M Groudine
Journal:  Genes Dev       Date:  1990-01       Impact factor: 11.361

2.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

3.  Onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient.

Authors:  R Dalla-Favera; F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1982-09-02       Impact factor: 49.962

4.  The structure and nucleotide sequence of the 5' end of the human c-myc oncogene.

Authors:  R Watt; K Nishikura; J Sorrentino; A ar-Rushdi; C M Croce; G Rovera
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

5.  Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients.

Authors:  G N Ranzani; N S Pellegata; C Previderè; A Saragoni; A Vio; M Maltoni; D Amadori
Journal:  Cancer Res       Date:  1990-12-15       Impact factor: 12.701

6.  Translocation and rearrangement of c-myc into immunoglobulin alpha heavy chain locus in primary cells from acute lymphocytic leukemia.

Authors:  C Peschle; F Mavilio; N M Sposi; A Giampaolo; A Caré; L Bottero; M Bruno; G Mastroberardino; R Gastaldi; M G Testa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

7.  Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues.

Authors:  M Piechaczyk; J M Blanchard; L Marty; C Dani; F Panabieres; S El Sabouty; P Fort; P Jeanteur
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

Review 8.  Translocations among antibody genes in human cancer.

Authors:  P Leder; J Battey; G Lenoir; C Moulding; W Murphy; H Potter; T Stewart; R Taub
Journal:  Science       Date:  1983-11-18       Impact factor: 47.728

9.  Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas.

Authors:  R Dalla-Favera; S Martinotti; R C Gallo; J Erikson; C M Croce
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

10.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.